3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Other solid neoplasm
1
Gynecologic
1
Gastrointestinal
1
Conditions
Sarcoma
26
Gliosarcoma
22
Glioblastoma
21
Glioma
16
Ependymoma
15
Astrocytoma
12
Osteosarcoma
11
Oligodendroglioma
11
Central Nervous System Neoplasms
10
Rhabdomyosarcoma
9
Medulloblastoma
9
Sarcoma, Ewing
7
Neuroblastoma
7
Glioma, Subependymal
7
Brain Neoplasms
7
Rhabdoid Tumor
6
Neuroectodermal Tumors, Primitive, Peripheral
6
Neuroectodermal Tumors, Primitive
6
Neoplasm Metastasis
6
Lymphoma, Non-Hodgkin
6
Lung Neoplasms
6
Histiocytosis, Langerhans-Cell
6
Carcinosarcoma
6
Wilms Tumor
5
Liposarcoma
5
Hepatoblastoma
5
Carcinoma, Transitional Cell
5
Sarcoma, Kaposi
4
Ovarian Neoplasms
4
Meningioma
4
Interventions
Cyclophosphamide
9
Doxorubicin
8
Vincristine
6
Etoposide
6
Ifosfamide
5
Filgrastim
5
Radiotherapy
4
fludarabine phosphate
3
Topotecan
3
Thiotepa
3
Peripheral Blood Stem Cell Transplantation
3
Melphalan
3
Cisplatin
3
Carboplatin
3
seclidemstat
2
Temozolomide
2
Tacrolimus
2
Neoadjuvant Therapy
2
Irinotecan
2
Injections
2
Hyperthermic Intraperitoneal Chemotherapy
2
Granulocyte Colony-Stimulating Factor
2
Epirubicin
2
Dactinomycin
2
Cytoreduction Surgical Procedures
2
Cyclosporine
2
Chemotherapy, Adjuvant
2
Brachytherapy
2
thymoglobulin
1
tazemetostat
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Desmoplastic Small Round Cell Tumor
×
Magnetic Resonance Spectroscopy
×
Sarcoma
×
Clear all
NCT04213794
2025-02-20
TOASTIT
Mayo Clinic
Phase EARLY_PHASE1
Terminated
2 enrolled